Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glucose transporters are membrane proteins that facilitate the movement of glucose across cell membranes. The GLUT family mediates facilitated diffusion down the glucose concentration gradient, while the SGLT family uses the sodium gradient to drive active uptake. Different isoforms are expressed in various tissues and play critical roles in glucose homeostasis, nutrient absorption, and renal reabsorption. Dysregulation of glucose transporters is implicated in diseases such as diabetes and cancer.
Facilitated diffusion (GLUTs) or secondary active transport (SGLTs) of glucose across cell membranes. SGLT2 inhibitors block reabsorption of glucose in the kidney, increasing urinary glucose excretion.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glucose Transporter (GLUT/SGLT).